Quick answer: Melanotan-1 and Melanotan-2 are synthetic melanocortin research peptides with distinct structures and receptor profiles. Melanotan-1 is a linear peptide analog of α-MSH, while Melanotan-2 is a cyclic peptide analog with different receptor subtype selectivity. Confirming identity and purity via a detailed Certificate of Analysis (COA) is essential for research validity.
Structural and Chemical Differences
Melanotan-1 (also known as Afamelanotide) is a linear peptide analog of the endogenous melanocortin agonist α-melanocyte-stimulating hormone (α-MSH). Its amino acid sequence is Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2, with a molecular weight of approximately 1716.9 Da. [1]
Melanotan-2 is a cyclic heptapeptide analog with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 and a molecular weight of about 1024.2 Da. The cyclic structure confers enhanced metabolic stability and receptor affinity compared to linear peptides. [2][3]
The cyclic nature of Melanotan-2 restricts conformational flexibility, often resulting in improved receptor selectivity and potency, which differs from the more flexible linear Melanotan-1.
Receptor Pharmacology and Selectivity
Both peptides act as agonists at melanocortin receptors (MCRs), a family of G protein-coupled receptors with five known subtypes: MC1R through MC5R. These receptors differ in tissue distribution and physiological roles.
Melanotan-1 shows high affinity and agonist activity primarily at MC1R, which regulates melanogenesis (pigmentation). It has been used in research to stimulate melanin production in skin cells. [4]
Melanotan-2 exhibits broader melanocortin receptor agonism, with potent activity at MC1R and significant activity at MC3R and MC4R, receptors implicated in energy homeostasis and sexual function in animal models. This broader receptor activity profile is attributed to its cyclic conformation. [5][6]
Reported EC50 values from in vitro assays suggest Melanotan-2 has sub-nanomolar potency at MC1R and MC4R, while Melanotan-1’s potency is somewhat lower but selective for MC1R. [5]
Analytical Verification and Documentation
Given the structural similarities and overlapping receptor activity, distinguishing Melanotan-1 from Melanotan-2 requires rigorous analytical verification. A comprehensive Certificate of Analysis (COA) should include:
- High-Performance Liquid Chromatography (HPLC): Purity ≥ 95% is standard; chromatograms should show a single dominant peak with retention times specific to the peptide batch.
- Mass Spectrometry (MS): Confirmation of exact monoisotopic mass (e.g., 1716.9 Da for Melanotan-1, 1024.2 Da for Melanotan-2) and isotopic pattern.
- Amino Acid Analysis or Peptide Mapping: To confirm sequence integrity.
- Impurity Profile: Identification and quantification of degradants or related substances.
- Stability Data: Shelf life and storage conditions validated by accelerated stability testing.
- Sterility and Endotoxin Testing: Important for cell culture or in vivo research applications.
Independent third-party verification of each batch is recommended to ensure reproducibility and research reliability. [7]
Historical and Research Context
Melanotan-1 was developed initially to explore pigmentation regulation and photoprotection in skin cells, with applications in laboratory and animal studies focusing on melanin synthesis pathways. [4]
Melanotan-2 emerged as a cyclic analog with enhanced potency and broader receptor activity, leading to its use in research related to energy balance and sexual behavior in animal models. Its cyclic structure contributes to greater metabolic stability and receptor selectivity. [5][6]
Summary Table
| Feature | Melanotan-1 | Melanotan-2 |
|---|---|---|
| Type | Linear synthetic melanocortin analog | Cyclic synthetic melanocortin analog |
| Molecular Weight | ~1716.9 Da | ~1024.2 Da |
| Structure | Linear peptide | Cyclic heptapeptide |
| Primary Receptor Affinity | MC1R selective | MC1R, MC3R, MC4R potent agonist |
| Analytical Verification | HPLC, MS, amino acid analysis, stability | HPLC, MS, amino acid analysis, stability |
Research-Use-Only Disclaimer
These peptides are intended strictly for laboratory research use. They are not approved for human or veterinary use. Research findings are based on in vitro and animal studies and should not be extrapolated to humans.
References
Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide — Cell Res (2021). PMID: 34561620
The melanocortin receptors as targets for general obesity: contextualizing clinical failures and analyzing future perspectives — Front Endocrinol (Lausanne) (2026). PMID: 41907544
Chemical and biological profile of Melanotan II — Peptides (2020). [DOI:10.1016/j.peptides.2020.170398]
Afamelanotide (Melanotan-1) pharmacology and clinical development — Expert Opin Investig Drugs (2012). PMID: 22717885
Pharmacological characterization of Melanotan II at melanocortin receptors — Eur J Pharmacol (2011). PMID: 21719067
Melanocortin receptor subtype selectivity and functional activity of cyclic peptide analogs — J Med Chem (2015). PMID: 25680240
Guidelines for peptide purity and analytical verification in research — J Pharm Biomed Anal (2019). [DOI:10.1016/j.jpba.2019.07.028]
Peptide Hackers offers both Melanotan-1 and Melanotan-2 with detailed COAs including HPLC, mass spectrometry, and stability data, verified by a third-party lab. You may arrange local pickup by appointment at our Los Angeles or Newport Beach locations. See the COA and order details on our Certificate of Analysis page.
All products are for laboratory research only. Not for human or veterinary use.
Research Use Only
This article is provided for educational purposes. All peptides discussed are sold for research use only and are not intended for human consumption or therapeutic use.